Key Takeaways
📈 Hillenbrand’s dividend yield currently stands at 2.85%, supported by free cash flow that meaningfully exceeds the annual dividend obligation, though the elevated payout ratio relative to reported earnings warrants close monitoring.
💵 Free cash flow of $271.7 million provides a solid buffer for the dividend, even as net income of $34.5 million and operating cash flow of $40.1 million remain modest against the backdrop of a $2.5 billion revenue base.
🧐 Analyst coverage is thin, with a single price target of $32.00 sitting just a hair above the current price of $31.98, suggesting the market has largely priced in near-term expectations with limited near-term upside catalyst from the Street.
Updated 2/24/26
Hillenbrand, Inc. is a diversified industrial company that has undergone a significant strategic transformation, moving away from its legacy funeral products business toward advanced processing solutions and engineered equipment. With operations spanning the food, plastics, and pharmaceuticals sectors, the company is focused on long-term growth through streamlined operations, disciplined capital allocation, and a deliberate shift toward higher-margin markets.
Despite the ongoing repositioning effort, Hillenbrand has returned to modest profitability, generating positive net income and substantial free cash flow. The stock has recovered meaningfully from its 2025 lows, and management continues to press forward with its margin improvement and cost discipline agenda while maintaining the dividend.
🕒 Recent Events
Hillenbrand has continued its portfolio transformation through the period leading up to early 2026, with management working through the operational integration of its remaining industrial businesses following the divestiture of the Milacron injection molding and extrusion segment. The company has been actively rationalizing its cost structure and streamlining its Advanced Process Solutions and Molding Technology Solutions segments to improve throughput and margins in a challenging capital equipment demand environment.
The company also navigated ongoing tariff headwinds and supply chain complexity during this stretch, implementing price surcharges and broadening its supplier base in response to inflationary cost pressures. These steps, while not immediately reflected in GAAP profitability, have contributed to protecting operating margins at the segment level. Management has also continued to signal its commitment to deleveraging, prioritizing debt reduction as a use of free cash flow alongside the dividend.
With the stock having climbed from a 52-week low of $18.36 to a recent price near $31.98, investor sentiment has improved considerably. The 52-week high of $35.22 remains within reach, and Hillenbrand’s recovery from the deep discount levels seen in mid-2025 reflects growing confidence that the worst of the earnings pressure may be passing.
📊 Key Dividend Metrics
🔵 Forward Dividend Yield: 2.85%
🟢 Annual Dividend Rate: $0.91
🟠 Payout Ratio (GAAP EPS): 184.18%
🔴 Free Cash Flow: $271,724,992
🟡 Last Quarterly Payment: $0.2275
🟣 Book Value Per Share: $19.54
The yield of 2.85% is respectable for the industrials sector, though it sits well below the elevated levels income investors saw when the stock was trading near its lows in 2025. The payout ratio, calculated against GAAP EPS of $0.49, looks alarming at 184%, but free cash flow tells a very different story, one that makes the dividend far more defensible than the headline ratio implies.
💵 Dividend Overview
Hillenbrand has maintained a consistent record of quarterly dividend payments, and the most recent payment of $0.2275 per share represents a modest but meaningful step up from the $0.225 per share paid through most of 2025. The annualized rate now stands at approximately $0.91, continuing the company’s measured approach to shareholder returns even as the business works through its transformation.
That commitment to the dividend speaks to how management views the payout, not as a line item to be trimmed at the first sign of trouble, but as a core element of the company’s relationship with shareholders. Through a period that included segment divestitures, margin compression, and elevated debt, Hillenbrand did not cut its dividend. That track record carries real weight for income-focused investors evaluating the stock today.
The caveat, as always with Hillenbrand at this stage of its cycle, is that the dividend rests more on free cash flow than on reported earnings. Net income of $34.5 million and operating cash flow of $40.1 million are both modest relative to the total annual dividend obligation. The strong free cash flow figure of $271.7 million fills that gap, but income investors should continue to track the relationship between earnings recovery and the sustainability of that cash generation over time.
📈 Dividend Growth and Safety
Reviewing the dividend history over the past several years shows a pattern of slow, deliberate increases that is entirely consistent with Hillenbrand’s identity as a steady compounder rather than a high-growth payout vehicle. The quarterly dividend moved from $0.22 in early 2023 to $0.2225 by the end of that year, held steady through most of 2024, then nudged up to $0.225 before reaching $0.2275 in December 2025. These are not dramatic jumps, but they represent a real commitment to growth even during a difficult operating period.
The safety of the dividend depends heavily on how one evaluates the cash flow picture. On a GAAP basis, the payout ratio of 184% would typically be a serious warning sign. But Hillenbrand’s free cash flow of $271.7 million dwarfs the total annual dividend cost, providing substantial coverage. The divergence between free cash flow and both net income and operating cash flow is worth examining closely, as it reflects timing differences and non-cash adjustments that investors should understand before drawing conclusions about sustainability.
The broader turnaround story is what ultimately determines whether the dividend is safe for the next several years. If Hillenbrand can translate its free cash flow strength into improving GAAP profitability and continue reducing its debt burden, the dividend should remain on solid footing. If earnings recovery stalls or macro conditions deteriorate further, the conversation about dividend coverage will become more urgent. For now, the cash flow runway is long enough to afford patience, but this payout requires ongoing attention rather than passive confidence.
Chart Analysis
Hillenbrand’s price action over the past year tells a compelling recovery story. Shares have surged from a 52-week low of $18.11 to a current price of $31.98, a gain of roughly 76.5% from trough to peak. That kind of move in under twelve months reflects a meaningful shift in market sentiment toward the name, and the fact that $31.98 also represents the 52-week high means the stock is pressing against fresh territory with no overhead resistance from prior price memory. For dividend investors who measure total return alongside income, this trajectory has been rewarding.
The moving average picture reinforces the bullish trend. HI is trading above both its 50-day moving average of $31.76 and its 200-day moving average of $26.02, and the 50-day has crossed above the 200-day to form what technicians call a golden cross. That configuration generally signals that shorter-term momentum has aligned with the longer-term trend, and it tends to attract systematic buyers who follow trend-following rules. The distance between the current price and the 200-day average, roughly 23%, illustrates just how far sentiment has shifted from where the stock was trading earlier in the year.
The one area that warrants measured attention is the RSI reading of 72.22. That puts HI in technically overbought territory, above the conventional 70 threshold, which can precede periods of consolidation or modest pullbacks as shorter-term traders take profits. This does not necessarily signal a trend reversal, particularly in a name with genuine fundamental momentum, but it does suggest that chasing the stock at the current price carries more timing risk than buying into a period of calm.
For dividend investors, the overall technical picture is constructive, with the caveat that patience may be rewarded here. The trend is clearly upward, the moving average structure is healthy, and the stock’s ability to hold at its 52-week high rather than retreat from it speaks to underlying demand. Investors comfortable with a modest near-term consolidation who are focused on the income stream and longer-term total return should find the current setup encouraging, even if the ideal entry may come on a slight pullback that allows the RSI to cool toward more neutral levels.
Cash Flow Statement
Watts Water Technologies… actually, let me check — this is Hillenbrand (HI). Hillenbrand’s cash flow profile tells a nuanced story that dividend investors need to read carefully. Operating cash flow surged from $63.3 million in 2022 to $207.0 million in 2023, held reasonably firm at $191.3 million in 2024, and then dropped sharply to $56.2 million in the trailing twelve months through 2025. Free cash flow followed a similar arc, climbing from $25.0 million in 2022 to a peak of $137.7 million in 2023 before cooling to $137.1 million in 2024 and then compressing to just $17.9 million in 2025. The TTM free cash flow figure of $271.7 million stands in striking contrast to the 2025 annual number, which suggests meaningful timing differences in how capital expenditures and working capital are flowing through the books. At $17.9 million in annual free cash flow, dividend coverage would be razor thin against the company’s current payout obligations, making the TTM figure the more constructive lens for near-term sustainability.
Zooming out across the full period, the 2023 and 2024 results demonstrated that Hillenbrand can generate genuinely strong free cash flow when operations are running efficiently, and the company’s capital expenditure discipline during those years kept the gap between operating and free cash flow relatively contained. The concern for income investors centers on the 2025 deterioration, which reflects both integration costs tied to the Schenck Process acquisition and broader industrial demand softness across its Process Equipment Group. If the TTM free cash flow of $271.7 million is a leading indicator of normalization rather than an anomaly, the dividend looks well covered and the trajectory becomes constructive again. However, investors should monitor whether the 2025 annual figures represent a temporary trough or the beginning of a more persistent compression in earnings quality, because the distance between the $17.9 million annual FCF reading and the current dividend commitment leaves very little room for further operational slippage.
Analyst Ratings
Analyst coverage of Hillenbrand is notably thin as of February 2026, with just one analyst providing a formal price target. That target is set at $32.00, which sits almost precisely in line with the current stock price of $31.98, implying essentially no near-term upside in the eyes of the lone covering analyst. The price target range of $32.00 at both the low and high end reflects the absence of a broader consensus, making it difficult to draw strong conclusions from the Street about the stock’s directional outlook.
The limited analyst coverage itself is a data point worth considering. Hillenbrand has undergone significant structural changes over the past two years, including the sale of major business segments, and that kind of transition can temporarily reduce institutional attention as analysts reassess the company’s earnings model and forward comparables. As the new Hillenbrand takes shape and reporting becomes more straightforward, coverage could broaden, which would provide a clearer read on where the professional investment community stands.
In the absence of active analyst upgrades or target revisions, investors are largely left to evaluate the stock on fundamental merit. The stock’s recovery from its 52-week low of $18.36 to the current $31.98 suggests that the market itself has been doing significant re-rating work, even without a strong analyst consensus driving the move. Whether that re-rating has run its course or has further to go depends on the trajectory of earnings and margin improvement in the quarters ahead.
Earning Report Summary
A Business Finding Its Footing
Hillenbrand’s most recently reported results reflect a company that has moved from net losses back into positive territory, with net income of $34.5 million and EPS of $0.49 on revenue of approximately $2.52 billion. That topline represents a meaningful reduction from prior periods when the company was operating a broader set of businesses, and investors should interpret the revenue figure in light of the Milacron divestiture and other portfolio changes that have reshaped Hillenbrand’s footprint. The leaner revenue base is by design, not distress.
Operating performance remains constrained by a thin profit margin of 1.37% and a return on equity of just 3.12%, both of which reflect how early the company is in its recovery and margin improvement journey. Operating cash flow of $40.1 million is positive but modest, and the contrast with free cash flow of $271.7 million points to the influence of non-operating cash events on the overall cash generation picture during this period.
Leadership’s Outlook and Strategy
CEO Kim Ryan and CFO Robert VanHimbergen have both emphasized continued focus on cost discipline, pricing strategy, and deleveraging as the primary near-term priorities. The company has been working to offset input cost inflation through targeted surcharges and supply chain diversification, while simultaneously investing in productivity improvements within its Advanced Process Solutions operations. Management has also pointed to stable demand in food, health, and nutrition end markets as an anchor for near-term revenue visibility, even as capital equipment order cycles in other segments remain uncertain.
The emphasis on free cash flow as a measure of business health has been consistent from the management team, and the strength of that metric relative to reported earnings suggests they are managing the business with cash generation, not just income statement optics, in mind. That discipline is a positive signal for dividend investors.
What’s Next
The key question for Hillenbrand heading through 2026 is whether GAAP profitability can catch up to the free cash flow strength the company has already demonstrated. If operating cash flow improves and the gap between free and operating cash flow narrows toward more normal levels, the earnings recovery story becomes considerably more credible. Investors watching the next several earnings releases should focus on segment margin trends, order book dynamics in Advanced Process Solutions, and the pace of debt reduction as the clearest indicators of whether the transformation is delivering as promised.
Management Team
Hillenbrand’s leadership continues to be anchored by CEO Kim Ryan, who has been in the role since December 2021 and brings more than three decades of institutional knowledge of the company’s operations. Her tenure predates her CEO appointment by many years, having held leadership positions at Batesville and Coperion, and that depth of operational experience has been evident in how she has managed the portfolio transformation without abandoning the company’s commitment to dividends and long-term capital discipline.
CFO Robert VanHimbergen, who joined in April 2022 from Johnson Controls where he served as Vice President and Corporate Controller, has played a central role in managing the company’s balance sheet through a period of elevated leverage and strategic portfolio activity. His financial background has been well-suited to the task of navigating asset sales, debt management, and cash flow optimization simultaneously. The combination of Ryan’s operational depth and VanHimbergen’s financial rigor gives Hillenbrand a leadership team that is well-matched to the demands of this particular phase of the company’s evolution.
The broader executive team includes Chief Human Resources Officer Aneesha Arora and Chief Information Officer Bhavik Soni, whose cross-industry experience adds meaningful capability to the organization as it modernizes its systems and talent infrastructure in parallel with the strategic transformation of its business mix.
Valuation and Stock Performance
Hillenbrand’s stock has staged a substantial recovery from the depths of its 2025 selloff, climbing from a 52-week low of $18.36 to a current price of $31.98, within striking distance of the 52-week high of $35.22. That move represents a near doubling off the lows and reflects a meaningful shift in investor sentiment as concerns about the company’s earnings trajectory and balance sheet durability have moderated. The stock now trades at a price-to-book ratio of 1.64 against a book value per share of $19.54, a notable re-rating from the depressed multiples seen during the worst of the selloff.
The P/E ratio of 65.27 looks elevated in isolation, but it reflects the thin GAAP earnings base of $0.49 per share rather than any irrational optimism about growth. As net income recovers toward levels more consistent with the company’s free cash flow generation, that multiple should compress materially. The market cap of approximately $2.26 billion against revenue of $2.52 billion implies a price-to-sales ratio near 0.90, which is reasonable for an industrial company in the midst of a margin recovery. The beta of 1.39 is a reminder that Hillenbrand’s stock moves with meaningful sensitivity to broader market sentiment, which income investors should factor into position sizing decisions.
Risks and Considerations
Hillenbrand’s payout ratio of 184% against reported EPS is the most immediate concern for dividend investors. While free cash flow of $271.7 million provides robust coverage of the annual dividend obligation, the gap between GAAP earnings and cash generation introduces uncertainty about how long that support can persist if operating performance does not improve. Any deterioration in free cash flow, particularly if it reflects a normalization of the investing-related inflows that appear to have boosted the metric during this period, would put the dividend in a more difficult position quickly.
The company’s debt load remains elevated, and while management has been prioritizing deleveraging, the combination of high leverage and thin operating margins leaves limited financial flexibility if macroeconomic conditions deteriorate. A slowdown in capital equipment demand, particularly in the plastics or pharmaceuticals end markets, could compress revenue further and make debt service more burdensome relative to cash generation.
Global economic uncertainty, including trade tensions and tariff-related cost pressures, continues to represent a meaningful operational risk. Hillenbrand has responded by adjusting pricing and diversifying its supplier base, but these measures provide partial rather than complete protection, and a renewed escalation in trade friction could erode the margin gains management has been working to achieve.
Finally, the thinness of analyst coverage, with only one analyst tracking the stock formally, means that information flow to the market is limited and that the stock could be more susceptible to sharp moves on earnings surprises or guidance changes than a more widely covered industrial name. Income investors should be prepared for elevated volatility relative to what the modest 2.85% yield might suggest at first glance.
Final Thoughts
Hillenbrand is a company that has come a long way from the distressed conditions that defined much of 2025, and the stock’s recovery from $18.36 to nearly $32.00 reflects genuine progress in stabilizing the business. The dividend, now at $0.2275 per quarter, has held firm and even grown modestly through a genuinely difficult stretch, which says something meaningful about management’s commitment to income investors. The free cash flow picture, while needing some scrutiny around its composition, is strong enough to support the payout for the foreseeable future.
The path forward is not without its complications. GAAP profitability remains thin, debt is elevated, and the margin recovery that management has been promising for several quarters is still more potential than reality in the reported numbers. But with the stock trading close to the lone analyst’s $32.00 price target and with the 52-week high of $35.22 as a plausible near-term ceiling, Hillenbrand sits at an interesting juncture. Income investors who already hold the stock have reason for cautious optimism. Those considering initiating a position should weigh the 2.85% yield and recovery potential against the real execution risks that remain, and watch the operating cash flow trend closely as the clearest signal of whether the transformation is truly taking hold.